ロード中...
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report
BACKGROUND: Gemcitabine is currently the standard chemotherapy for the adjuvant treatment of pancreatic cancer. This chemotherapeutic agent is generally well-tolerated, myelosuppression and gastrointestinal toxicity being common side effects. Nevertheless, gemcitabine-induced pulmonary toxicity has...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059971/ https://ncbi.nlm.nih.gov/pubmed/27733144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2833-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|